Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
EPE Special Opportunities Limited | EP0 | Nov 15, 2024 | 1.87 | 0.00 |
EPENDION AB SK 0,3333 | TW4 | Nov 15, 2024 | 8.46 | +0.36 |
Epigenomics AG | ECX | Nov 15, 2024 | 1.01 | -1.94 |
Epiroc A | 3AD1 | Nov 15, 2024 | 16.92 | -0.21 |
EPIROC AB UNSP.ADR/1 | 3ADA | Nov 15, 2024 | 16.60 | -0.60 |
Epiroc B | 3AD2 | Nov 15, 2024 | 15.21 | -0.78 |
Episurf Medical B | 16E | Nov 15, 2024 | 0.01 | +9.80 |
ePlay Digital Inc | 2NY2 | Nov 15, 2024 | 0.00 | 0.00 |
ePlus inc. | MLE | Nov 15, 2024 | 74.00 | -1.33 |
EPR Properties | E2H | Nov 15, 2024 | 41.55 | -3.28 |
EPRCOMUNICAZIONE S.P.A. | J3P | Nov 15, 2024 | 1.23 | 0.00 |
EPTI AB AK | G7H0 | Nov 15, 2024 | 1.71 | 0.00 |
Epwin Group Plc | 2E3 | Nov 15, 2024 | 1.23 | 0.00 |
EQB INC. | V22 | Nov 15, 2024 | 73.00 | 0.00 |
EQL Pharma | 7JK | Nov 15, 2024 | 5.64 | +4.06 |
EQT | 6EQ | Nov 15, 2024 | 25.40 | -0.39 |
EQT Corporation | EQ6 | Nov 15, 2024 | 39.99 | -1.87 |
Eqtec | KEU | Nov 15, 2024 | 0.01 | 0.00 |
Equals Group Plc | 2FX | Nov 15, 2024 | 1.47 | 0.00 |
Equatorial Resources Limited | PBU | Nov 15, 2024 | 0.06 | +7.48 |
Equifax, Inc. | EFX | Nov 15, 2024 | 246.00 | -1.60 |
Equillium, Inc. | 0FY | Nov 15, 2024 | 1.16 | 0.00 |
Equinix, Inc. | EQN2 | Nov 15, 2024 | 842.60 | -0.78 |
Equinor | DNQ | Nov 15, 2024 | 22.63 | +0.58 |
Equinor ASA | DNQA | Nov 15, 2024 | 22.60 | +1.35 |
Equinox Gold Corp | 1LRC | Nov 15, 2024 | 4.88 | +0.43 |
EQUIPMAKE HLDGS LS -,0001 | U8O | Nov 15, 2024 | 0.03 | 0.00 |
Equitable Holdings Inc | AXJ | Nov 15, 2024 | 44.20 | -1.34 |
Equity Bancshares, Inc. - Class A | 44X | Nov 15, 2024 | 43.40 | -2.25 |
Equity Commonwealth | HP5A | Nov 15, 2024 | 18.90 | +1.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.